Evidence map›Paper›PMID 36448779›Full record

ArticlemSphere2022

Epidemiological and Genomic Analysis of a Large SARS-CoV-2 Outbreak in a Long-Term Care Facility in Catalonia, Spain.

Antoni E Bordoy, Xavier Vallès, Anna Not, Álvaro Chiner-Oms, Verónica Saludes, Judit Torres Cervós, Anna Roset Roig, Concha Juan-Andres, Helena Sureda, Vanessa Pardo-Amil and 11 more

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 1 country.

Antoni E Bordoy *Microbiology Department, Laboratori Clínic Metropolitana Nord, Hospital Universitari Germans Trias i Pujol (HUGTiP), Badalona, Barcelona, Spain.ORCID 0000-0002-1165-542X
Xavier Vallès *Institut de Recerca Germans Trias i Pujol (IGTP), Badalona, Barcelona, Spain.
Anna NotInstitut de Recerca Germans Trias i Pujol (IGTP), Badalona, Barcelona, Spain.
Álvaro Chiner-OmsSeqCOVID-SPAIN consortium, Valencia, Spain.
Verónica SaludesMicrobiology Department, Laboratori Clínic Metropolitana Nord, Hospital Universitari Germans Trias i Pujol (HUGTiP), Badalona, Barcelona, Spain.
Judit Torres CervósFundació Pere Mata, Barcelona, Spain.
Anna Roset RoigFundació Pere Mata, Barcelona, Spain.
Concha Juan-AndresEquip d'Atenció Primària Alt Mogent, Direcció d'Atenció Primària Regió Metropolitana Nord, Institut Català de la Salut, Barcelona, Spain.
Helena SuredaEquip d'Atenció Primària Alt Mogent, Direcció d'Atenció Primària Regió Metropolitana Nord, Institut Català de la Salut, Barcelona, Spain.
Vanessa Pardo-AmilEquip d'Atenció Primària Alt Mogent, Direcció d'Atenció Primària Regió Metropolitana Nord, Institut Català de la Salut, Barcelona, Spain.
Irene GarcíaÀrea de Suport Assistencial, Direcció d'Atenció Primària-Vallès Oriental, Institut Català de la Salut, Barcelona, Spain.
Gemma Guitart RossellFundació Pere Mata, Barcelona, Spain.
Laura Cambra CibeiraFundació Pere Mata, Barcelona, Spain.
Cristina CasañMicrobiology Department, Laboratori Clínic Metropolitana Nord, Hospital Universitari Germans Trias i Pujol (HUGTiP), Badalona, Barcelona, Spain.
Montserrat GiménezMicrobiology Department, Laboratori Clínic Metropolitana Nord, Hospital Universitari Germans Trias i Pujol (HUGTiP), Badalona, Barcelona, Spain.
Ignacio BlancoMicrobiology Department, Laboratori Clínic Metropolitana Nord, Hospital Universitari Germans Trias i Pujol (HUGTiP), Badalona, Barcelona, Spain.
Manuela Torres-PuenteSeqCOVID-SPAIN consortium, Valencia, Spain.
Irving Cancino-MuñozSeqCOVID-SPAIN consortium, Valencia, Spain.
Fernando González-CandelasSeqCOVID-SPAIN consortium, Valencia, Spain.
Iñaki ComasSeqCOVID-SPAIN consortium, Valencia, Spain.
Elisa MartróMicrobiology Department, Laboratori Clínic Metropolitana Nord, Hospital Universitari Germans Trias i Pujol (HUGTiP), Badalona, Barcelona, Spain.ORCID 0000-0002-2867-6649
Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol · ESFundacio Pere Tarres · ESInstitut Català de la Salut · ESInstituto de Biomedicina de Valencia · ESHospital Universitari Germans Trias i Pujol · ESUniversitat de València · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Limiting outbreaks in long-term care facilities (LTCFs) is a cornerstone strategy to avoid an excess of COVID-19-related morbidity and mortality and to reduce its burden on the health system. We studied a large outbreak that occurred at an LTCF, combining methods of classical and genomic epidemiology analysis. The outbreak lasted for 31 days among residents, with an attack rate of 98% and 57% among residents and staff, respectively. The case fatality rate among residents was 16% (

Indexed as

COVID-19SARS-CoV-2Disease OutbreaksGenomicsHumansLong-Term CarePhylogenySpainCOVID-19occupational riskresidential facilitiesSARS-CoV-2transmission

Identifiers

PMID36448779
PMCPMC9769531
OpenAlexW4310398125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.